Biotech Co. Says Brewer's Kombucha Teas Infringe Its IP

By Kurt Orzeck (April 13, 2016, 7:04 PM EDT) -- Ganeden Biotech Inc. slapped a Washington brewery and a California kombucha producer with a suit in Ohio federal court Wednesday accusing them of infringing at least one of Ganeden's patents for a probiotic bacteria and engaging in unfair competition.

The Ohio-based Ganeden says it has a patent covering any tea products containing Bacillus coagulans, as well as another that covers tea and other products with a specific strain of the bacteria.

American Brewing Co. Inc. and B&R Liquid Adventure LLC allegedly sold teas with Bacillus coagulans and labeled as having the GBI-30 strain, also called GanedenBC.

The suit claims that if...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!